How to manage osteoporosis in children

Research output: Contribution to journalArticle

Abstract

Osteoporosis is increasingly being seen in young people. The primitive forms are relatively rare, but the secondary forms-particularly in long-term corticosteroid therapy-are a relevant problem given the much longer survival in chronic diseases such as cystic fibrosis, chronic renal insufficiency, leukaemia, and Duchenne muscular dystrophy. Controlled, prospective studies to evaluate the results of prevention and therapy in children are still lacking. The basis of therapy is the correct daily intake of calcium and the use of vitamin D (or active metabolites). This helps the growing skeleton to restore its equilibrium in many cases. Restraining the long-term use of corticosteroids to the minimum effective dose and shorter duration is essential. In severe cases, particularly in the presence of fractures, bisphosphonates can be remarkably effective. In some cases, such as idiopathic juvenile osteoporosis, the rule is spontaneous resolution, and the advisability of an aggressive drug therapy is discussed.

Original languageEnglish
Pages (from-to)991-1005
Number of pages15
JournalBest Practice and Research: Clinical Rheumatology
Volume19
Issue number6
DOIs
Publication statusPublished - Dec 2005

    Fingerprint

Keywords

  • Adolescents
  • Bisphosphonates
  • Bone density (bone mineral density)
  • Bone mass
  • Calcium
  • Children
  • Densitometry
  • Fractures
  • Osteogenesis imperfecta
  • Osteoporosis
  • Vitamin D

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine
  • Rheumatology

Cite this